Global Prostate Cancer Patient Insights and Epidemiology - 2016

  • ID: 3692135
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Prostate Cancer Patient Insights and Epidemiology – 2016, provides insights into total Prostate Cancer patients on drug therapies in top 7 markets, Prostate Cancer treatable patients, and Prostate Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Prostate Cancer specialists, oncologists, and Prostate Cancer patients to identify the Prostate Cancer patients in top 7 markets who were treated by drug therapies. The research also identifies total Prostate Cancer patients’ on drug therapies by Prostate Cancer stages.
Prostate cancer patients were given hormone therapies and chemotherapies as a part of their treatment. Hormone therapy is also called androgen deprivation therapy (ADT) or androgen suppression therapy. This study accurately determines and forecast Prostate Cancer patients who were on drug therapies in a given year. This research also provides insights into Prostate Cancer epidemiology including Prostate Cancer incidence and Prostate Cancer prevalence by Prostate Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Prostate Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Prostate Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Prostate Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Prostate Cancer Patients on drug therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Prostate Cancer market potential, Prostate Cancer drug therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Prostate Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on drug therapies
3. Prostate Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on drug therapies
4. Prostate Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on drug therapies
5. Prostate Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on drug therapies
6. Prostate Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on drug therapies
7. Prostate Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on drug therapies
8. Prostate Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on drug therapies
9. Prostate Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on drug therapies
10. Glossary

1. Prostate Cancer Incidence by Stages, Global, 2010 - 2025
2. Prostate Cancer Prevalence by Stages, Global, 2010 - 2025
3. Prostate Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Prostate Cancer Patients on drug therapies by Stages, Global, 2010 – 2025
5. Prostate Cancer Incidence by Stages, Germany, 2010 - 2025
6. Prostate Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Prostate Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Prostate Cancer Patients on drug therapies by Stages, Germany, 2010 - 2025
9. Prostate Cancer Incidence by Stages, France, 2010 - 2025
10. Prostate Cancer Prevalence by Stages, France, 2010 - 2025
11. Prostate Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Prostate Cancer Patients on drug therapies by Stages, France, 2010 - 2025
13. Prostate Cancer Incidence by Stages, Italy, 2010 - 2025
14. Prostate Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Prostate Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Prostate Cancer Patients on drug therapies by Stages, Italy, 2010 - 2025
17. Prostate Cancer Incidence by Stages, Spain, 2010 - 2025
18. Prostate Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Prostate Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Prostate Cancer Patients on drug therapies by Stages, Spain, 2010 - 2025
21. Prostate Cancer Incidence by Stages, UK, 2010 - 2025
22. Prostate Cancer Prevalence by Stages, UK, 2010 - 2025
23. Prostate Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Prostate Cancer Patients on drug therapies by Stages, UK, 2010 – 2025
25. Prostate Cancer Incidence by Stages, Japan, 2010 - 2025
26. Prostate Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Prostate Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Prostate Cancer Patients on drug therapies by Stages, Japan, 2010 – 2025
29. Prostate Cancer Incidence by Stages, US, 2010 - 2025
30. Prostate Cancer Prevalence by Stages, US, 2010 - 2025
31. Prostate Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Prostate Cancer Patients on drug therapies by Stages, US, 2010 - 2025

1. Prostate Cancer Incidence, Global, 2010 – 2025
2. Prostate Cancer Incidence – Stage I, Global, 2010 – 2025
3. Prostate Cancer Incidence – Stage II, Global, 2010 - 2025
4. Prostate Cancer Incidence – Stage III, Global, 2010 - 2025
5. Prostate Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Prostate Cancer Prevalence, Global, 2010 - 2025
7. Prostate Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Prostate Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Prostate Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Prostate Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Prostate Cancer Treatable Patients, Global, 2010 - 2025
12. Prostate Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Prostate Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Prostate Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Prostate Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Prostate Cancer Patients on drug therapies, Global, 2010 - 2025
17. Total Prostate Cancer Patients on drug therapies – Stage I, Global, 2010 – 2025
18. Total Prostate Cancer Patients on drug therapies – Stage II, Global, 2010 – 2025
19. Total Prostate Cancer Patients on drug therapies – Stage III, Global, 2010 – 2025
20. Total Prostate Cancer Patients on drug therapies – Stage IV, Global, 2010 – 2025
21. Prostate Cancer Incidence by Stages, Germany, 2010 – 2025
22. Prostate Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Prostate Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Prostate Cancer Patients on drug therapies, Germany, 2010 - 2015
25. Prostate Cancer Incidence by Stages, France, 2010 – 2025
26. Prostate Cancer Prevalence by Stages, France, 2010 – 2025
27. Prostate Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Prostate Cancer Patients on drug therapies, France, 2010 – 2025
29. Prostate Cancer Incidence by Stages, Italy, 2010 – 2025
30. Prostate Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Prostate Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Prostate Cancer Patients on drug therapies, Italy, 2010 – 2025
33. Prostate Cancer Incidence by Stages, Spain, 2010 – 2025
34. Prostate Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Prostate Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Prostate Cancer Patients on drug therapies, Spain, 2010 - 2015
37. Prostate Cancer Incidence by Stages, UK, 2010 – 2025
38. Prostate Cancer Prevalence by Stages, UK, 2010 – 2025
39. Prostate Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Prostate Cancer Patients on drug therapies, UK, 2010 – 2025
41. Prostate Cancer Incidence by Stages, Japan, 2010 – 2025
42. Prostate Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Prostate Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Prostate Cancer Patients on drug therapies, Japan, 2010 – 2025
45. Prostate Cancer Incidence by Stages, US, 2010 – 2025
46. Prostate Cancer Prevalence by Stages, US, 2010 – 2025
47. Prostate Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Prostate Cancer Patients on drug therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll